Use of compounds in the treatment of dyskinesia

Details Use of compounds in the treatment of dyskinesia Use of compounds in the treatment of dyskinesia

A - Human Necessities

61

K

A61K 31/70 (2006.01) A61K 31/18 (2006.01) A61K 31/35 (2006.01) A61P 25/14 (2006.01)

Patent

CA 2499200

The present invention relates to the treatment of dyskinesia with compounds of General Formula (I) such as topiramate. The compound may be topiramate or a derivative thereof. The dyskinesia may be associated with a basil ganglia- related movement disorder such as parkinsonism and may also arise as a side- effect of other therapeutic agents (e.g. L-DOPA).

L'invention concerne le traitement de la dyskinésie au moyen de composés de formule générale (I), tels que le topiramate. Le composé peut être du topiramate ou un dérivé de celui-ci. La dyskinésie peut être associée à un trouble du mouvement relatif aux noyaux gris centraux, tel que le syndrome parkisonien et elle peut également apparaître sous la forme d'un effet secondaire d'autres agents thérapeutiques (par exemple, L-DOPA).

Affiliated with

Also associated with

Rating

Use of compounds in the treatment of dyskinesia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of compounds in the treatment of dyskinesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of compounds in the treatment of dyskinesia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1368190